Skip to main content

Table 2 Overview of the AZM551248 study design

From: The role of microRNAs in the pathogenesis of MMPi-induced skin fibrodysplasia

Group

Animal Number

Treatment

Duration of Treatment (days)

Daily Dose (mg/kg/day)

1

1–5

Vehicle

17

0

2

6–10

AZM551248

4

20

3

11–15

AZM551248

8

20

4

16–20

AZM551248

11

20

5

21–25

AZM551248

14

20

6

26–30

AZM551248

17

20